Brawn Laboratories Limited Tetracycline Export Data — India (DGFT 2022–2026)

Name: Brawn Laboratories Limited Tetracycline Export Records India — #12 Exporter, 8 Shipments, $288.8K FOB USD (DGFT 2022–2026)
Creator: TransData Nexus
Published: 2026-04-01T00:00:00Z
License: https://transdatanexus.com/terms-and-conditions

Suresh Sormare

Tetracycline

India Pharmaceutical Trade Intelligence

$16.9M263 Suppliers128 CountriesHS 30042049

ExportsIndia → TANZANIA15.9%India → UNITED STATES11.3%

ImportsCHINA → India$225.7M UNITED KINGDOM → India$506.7K

Brawn Laboratories Limited — Tetracycline Exporter #12 | $288.8K Trade Value | TransData Nexus | TransData Nexus

Brawn Laboratories Limited — Tetracycline Exporter Profile

Indian Pharmaceutical Exporter · #12 for Tetracycline · $288.8K export value · DGFT Verified

Brawn Laboratories Limited is the #12 Indian exporter of Tetracycline with $288.8K in export value and 8 verified shipments. Brawn Laboratories Limited holds a 1.7% market share in Tetracycline exports across 2 countries. The company exports 17 pharmaceutical products worth $22.6M across 10 therapeutic categories.

Brawn Laboratories Limited — Tetracycline Export Profile: Buyers & Destinations

Brawn Laboratories Limited Tetracycline export treemap — buyers and destination countries | TransData Nexus

Where Does India Export Tetracycline?

Country	Value	Shipments	Share
UNITED STATES	$1.9M	92	16.8%
TANZANIA	$1.9M	37	16.3%
CONGO DR	$1.5M	61	13.3%
ETHIOPIA	$1.5M	67

Who Are the Top Buyers of Tetracycline from India?

Buyer	Country	Value	Orders
STE PRINCE PHARMA SARL	CONGO DR	$1.8M	72
CARDINAL HEALTH	UNITED STATES	$1.5M	39
HEKO PHARMACY LTD	TANZANIA	$400.0K	8
PRINCE FARMA LDA,	ANGOLA	$251.9K	7
TROGE MEDICAL GMBH	GERMANY	$250.0K	5
IMRES B.V.	NETHERLANDS	$219.6K	12
ETHIOPIAN PHARMACEUTICALS SUPPLY	ETHIOPIA	$150.0K	3
UNICEF SUPPLY DIVISION	DENMARK	$100.0K	2
NEW CESAMEX S	CONGO	$100.0K	2
ETHIOPIAN PHARMACEUTICALS	ETHIOPIA	$100.0K	2

India's Tetracycline is purchased by 660 buyers worldwide. The top buyer is STE PRINCE PHARMA SARL (CONGO DR), followed by CARDINAL HEALTH and HEKO PHARMACY LTD.

How Does Brawn Laboratories Limited Compare to Nearest Tetracycline Exporters?

Exporters ranked immediately above and below #12 by export value

#	Supplier	Export Value	Shipments	Countries	Avg/Shipment
9	BRASSICA PHARMA PRIVATE LIMITED	$350.0K	7	3	$50.0K
11	CENTAUR PHARMACEUTICALS PRIVATE LIMITED	$311.5K	37	7	$8.4K
12	BRAWN LABORATORIES LIMITED ★	$288.8K	8	2	$36.1K
13	AURA LIFECARE PRIVATE LIMITED	$275.5K	7	4	$39.4K
14	GALENTIC PHARMA INDIA PRIVATE LIMITED	$269.3K	14	7	$19.2K

Brawn Laboratories Limited ranks #12 among 263 Indian Tetracycline exporters. Average shipment value of $36.1K compared to the market average of $36.8K. The closest competitors by value are BRASSICA PHARMA PRIVATE LIMITED and CENTAUR PHARMACEUTICALS PRIVATE LIMITED.

Which Indian Ports Ship Tetracycline Exports?

Port	Shipments	% Share
DELHI AIR CARGO ACC (INDEL4)	438	15.5%
SAHAR AIR CARGO ACC (INBOM4)	393	13.9%
SAHAR AIR	355	12.5%
DELHI AIR	253	8.9%
NHAVA SHEVA SEA (INNSA1)	224	7.9%
JNPT	130	4.6%
Bombay Air	121	4.3%
JNPT/ NHAVA SHEVA SEA	114	4.0%

Geopolitical & Trade Policy Impact on Brawn Laboratories Limited's Tetracycline Exports

Recent geopolitical developments have introduced significant challenges for Indian pharmaceutical exporters like Brawn Laboratories. The Israel-Iran tensions have escalated security risks in the Strait of Hormuz and the Red Sea–Suez Canal corridor, leading to major carriers suspending or restricting transits. This has resulted in extended transit times by 10–20 days and a 40–50% increase in freight rates on key India–Europe routes, as reported by industry executives and insurers. (livemint.com)

In the United States, policy shifts towards reshoring pharmaceutical manufacturing and imposing tariffs on imports have prompted Indian companies to invest in U.S. facilities. This strategy aims to mitigate tariff impacts and secure market access. For instance, Indian firms have invested between $500-700 million in U.S. hubs during the partial fiscal year 2025-26, focusing on oncology and biologics. (odrindia.in) Such investments are crucial for maintaining competitiveness in the U.S. market amidst evolving trade policies.

The European Union's regulatory landscape is also evolving, with stringent compliance requirements under the Falsified Medicines Directive. Indian exporters must navigate these regulations to ensure market access, emphasizing the need for robust quality assurance and compliance frameworks. Brawn Laboratories' adherence to these standards is vital for sustaining and expanding its European market presence.

Brawn Laboratories Limited — Regulatory Compliance & Quality Standards

Compliance with international quality standards is paramount for Indian pharmaceutical exporters. The U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA) have intensified inspections and enforcement actions, necessitating stringent adherence to Good Manufacturing Practices (GMP). Instances of non-compliance have led to import bans and reputational damage for some Indian firms. (comcec.org) Therefore, Brawn Laboratories must prioritize quality control and regulatory compliance to maintain its export licenses and market credibility.

The Indian government's initiatives to bolster the pharmaceutical sector's compliance infrastructure, including the establishment of a dedicated 'CBAM Facilitation Cell' to assist exporters with complex reporting requirements, reflect a commitment to enhancing global competitiveness. (sgeexport.com) Brawn Laboratories' proactive engagement with these initiatives can further strengthen its compliance posture.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Product Matching: Tetracycline shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
2.Supplier Identification: Brawn Laboratories Limited matched across shipments using name normalization, accounting for company name formatting variations.
3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

Global Coverage

Exports to 128+ countries, 660+ buyers

Expert-Reviewed

Analyzed by pharmaceutical trade specialists

Tetracycline

Tetracycline

Brawn Laboratories Limited — Tetracycline Exporter Profile

Brawn Laboratories Limited — Tetracycline Export Profile: Buyers & Destinations

Where Does India Export Tetracycline?

Who Are the Top Buyers of Tetracycline from India?

What Is India's Total Tetracycline Export Value and How Much Does Brawn Laboratories Limited Contribute?

What Is the Average Shipment Value for Brawn Laboratories Limited's Tetracycline Exports?

How Does Brawn Laboratories Limited Compare to Other Indian Tetracycline Exporters?

Regulatory Requirements: Exporting Tetracycline to Key Markets

United States — FDA

How Does Brawn Laboratories Limited Compare to Nearest Tetracycline Exporters?

Which Indian Ports Ship Tetracycline Exports?

What Other Antibiotics Products Does Brawn Laboratories Limited Export?

Geopolitical & Trade Policy Impact on Brawn Laboratories Limited's Tetracycline Exports

Brawn Laboratories Limited — Regulatory Compliance & Quality Standards

About Brawn Laboratories Limited

Market Intelligence

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

Analysis Methodology

Get Tetracycline Export Data from Brawn Laboratories Limited

Tetracycline Stats

Company Overview

Top Products by Brawn Laboratories Limited

Related Analysis

Need Detailed Export Data?

Data Source